Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies.

Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies.
复制标题

使用多价、多特异性抗体改善癌症治疗和分子成像。

DOI:
10.1089/cbr.2009.0690
复制
发表时间:
2010
影响因子:
3.4
通讯作者:
Goldenberg,DavidM
Goldenberg,DavidM
中科院分区:
医学4区
文献类型:
--
作者:
Sharkey,RobertM;Rossi,EdmundA;Chang,Chien-Hsing;Goldenberg,DavidM

文献摘要

参考文献

被引文献

相似文献

SummationAntibodies are highly versatile proteins with the ability to be used to target diverse compounds, such as radionuclides for imaging and therapy, or drugs and toxins for therapy, but also can be used unconjugated to elicit therapeutically beneficial responses, usually with minimal toxicity. This update describes a new procedure for forming multivalent and/or multispecific proteins, known as the dock-and-lock (DNL) technique. Developed as a procedure for preparing bispecific antibodies capable of binding divalently to a tumor antigen and monovalently to a radiolabeled hapten-peptide for pretargeted imaging and therapy, this methodology has the flexibility to create a number of other biologic agents of therapeutic interest. A variety of constructs, based on anti-CD20 and CD22 antibodies, have been made, with results showing that multispecific antibodies have very different properties from the respective parental monospecific antibodies. The technique is not restricted to antibody combination, but other biologics, such as interferon-α2b, have been prepared. These types of constructs not only allow small biologics to be sustained in the blood longer, but also to be selectively targeted. Thus, DNL technology is a highly flexible platform that can be used to prepare many different types of agents that could further improve cancer detection and therapy.
使用新型重组三价抗 CD20 双特异性抗体对非霍奇金淋巴瘤进行预靶向放射免疫治疗,改善了治疗效果。
DOI: 10.1158/0008-5472.can-08-0037
发表时间: 2008
期刊: Cancer research
影响因子: 11.2
作者:
Sharkey,RobertM;Karacay,Habibe;Litwin,Samuel;Rossi,EdmundA;McBride,WilliamJ;Chang,Chien-Hsing;Goldenberg,DavidM
通讯作者: Goldenberg,DavidM
使用放射性标记的抗癌胚抗原免疫球蛋白 G 对仓鼠中的 GW-39 肿瘤进行光扫描定位。
DOI: --
发表时间: 1974
期刊: Cancer Research
影响因子: 11.2
作者:
David M. Goldenberg;Preston Df;F. Primus;Hans J. Hansen
通讯作者: Hans J. Hansen
在裸鼠移植的大结肠癌的放射免疫治疗中,碘 131 标记的 MAb F(ab)2 片段比完整的抗 CEA 抗体更有效且毒性更小。
DOI: --
发表时间: 1990
影响因子: 9.3
作者:
F. Buchegger;A. Pèlegrin;B. Delaloye;A. Bischof;J. Mach
通讯作者: J. Mach
DOI: --
发表时间: 2003-01
期刊: Cancer research
影响因子: 11.2
作者:
R. Sharkey;W. Mcbride;H. Karacay;Ken Chang;G. Griffiths;H. Hansen;D. Goldenberg
通讯作者: R. Sharkey;W. Mcbride;H. Karacay;Ken Chang;G. Griffiths;H. Hansen;D. Goldenberg
DOI: 10.1182/blood-2009-06-228890
发表时间: 2009-10-29
期刊: BLOOD
影响因子: 20.3
作者:
Rossi, Edmund A.;Goldenberg, David M.;Chang, Chien-Hsing
通讯作者: Chang, Chien-Hsing